| Secondary |
| Pulmonary Arterial Hypertension |
25.1% |
| Drug Use For Unknown Indication |
16.0% |
| Acute Myocardial Infarction |
8.4% |
| Pulmonary Hypertension |
6.8% |
| Interstitial Lung Disease |
4.9% |
| Scleroderma |
4.6% |
| Anticoagulant Therapy |
3.4% |
| Hypertension |
3.4% |
| Arteriosclerosis Obliterans |
3.0% |
| Cardiac Disorder |
3.0% |
| Hyperlipidaemia |
3.0% |
| Anaemia |
2.3% |
| Collagen Disorder |
2.3% |
| Delirium |
2.3% |
| Tinea Infection |
2.3% |
| Dialysis |
1.9% |
| Inflammation |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Arterial Occlusive Disease |
1.5% |
|
| Interstitial Lung Disease |
13.3% |
| Renal Impairment |
8.3% |
| Toxic Epidermal Necrolysis |
8.3% |
| White Blood Cell Count Increased |
8.3% |
| Respiratory Failure |
6.7% |
| Transfusion |
6.7% |
| Tremor |
6.7% |
| Ventricular Tachycardia |
6.7% |
| Abdominal Cavity Drainage |
5.0% |
| Platelet Count Decreased |
5.0% |
| Epistaxis |
3.3% |
| Pneumonia |
3.3% |
| Pulmonary Alveolar Haemorrhage |
3.3% |
| Pulmonary Hypertension |
3.3% |
| Rhabdomyolysis |
3.3% |
| Arthralgia |
1.7% |
| Ascites |
1.7% |
| Delirium |
1.7% |
| Dyspnoea |
1.7% |
| Hepatic Function Abnormal |
1.7% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
25.0% |
| Pulmonary Hypertension |
17.2% |
| Product Used For Unknown Indication |
10.5% |
| Prophylaxis |
8.1% |
| Rheumatoid Arthritis |
7.7% |
| Drug Use For Unknown Indication |
7.0% |
| Scleroderma |
4.2% |
| Hypertension |
4.0% |
| Cardiac Failure |
3.5% |
| Arteriosclerosis Obliterans |
1.4% |
| Immune Thrombocytopenic Purpura |
1.4% |
| Osteoporosis |
1.4% |
| Gastrointestinal Mucosal Disorder |
1.2% |
| Atrial Fibrillation |
1.1% |
| Cerebral Infarction |
1.1% |
| Diabetes Mellitus |
1.1% |
| Gastroenteritis |
1.1% |
| Hypokalaemia |
1.1% |
| Insomnia |
1.1% |
| Arrhythmia |
1.0% |
|
| Death |
8.6% |
| Hepatic Function Abnormal |
6.9% |
| Liver Disorder |
6.3% |
| Cardiac Failure |
5.1% |
| Platelet Count Decreased |
5.1% |
| Pneumonia |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Vomiting |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Condition Aggravated |
4.6% |
| Pulmonary Hypertension |
4.6% |
| Renal Impairment |
4.6% |
| Rheumatoid Arthritis |
4.6% |
| Transient Ischaemic Attack |
4.6% |
| White Blood Cell Count Increased |
4.6% |
| Aspartate Aminotransferase Increased |
4.0% |
| Interstitial Lung Disease |
4.0% |
| Nausea |
4.0% |
| Right Ventricular Failure |
4.0% |
| Thrombocytopenia |
4.0% |
|
| Interacting |
| Pulmonary Hypertension |
100.0% |
|
| Dizziness |
50.0% |
| Malaise |
50.0% |
|
